Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Hicks

Showing results (91-100 of 470) with videos related to

Pageof 47
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 4, 2007
Overview of early response assessment in lymphoma with FDG-PETMichael P MacManus, John F Seymour, Rodney J Hicks
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Imaging, radiation oncology and randomised trials: time for a change?Gillian M Duchesne, Shih-Chang Wang, Rodney J Hicks
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 11, 2018
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and PitfallsMichael S Hofman, Rodney J Hicks, Tobias Maurer, et al.
The Lancet. Oncology|August 14, 2018
[<sup>177</sup>Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer - Author's replyMichael S Hofman, John Violet, Rodney J Hicks, et al.
ANZ Journal of Surgery|March 4, 2015
Re: palliative bypass for small bowel carcinoid with mesenteric mass and vascular encasementBenjamin N J Thomson, Michael S Hofman, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake valueThomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 6, 2022
Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasmsAmir Iravani, Ashwin Singh Parihar, Timothy Akhurst, et al.
Current Oncology Reports|April 2, 2008
The role of PET-CT in the management of patients with advanced cancer of the head and neckJune Corry, Danny Rischin, Rodney J Hicks, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodulesJason Callahan, Tomas Kron, Michal E Schneider, et al.
Seminars in Nuclear Medicine|August 16, 2005
Initial staging of lymphoma with positron emission tomography and computed tomographyRodney J Hicks, Michael P Mac Manus, John F Seymour
Pageof 47

Showing results (91-100 of 470) with videos related to

Sort By:
Pageof 47
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 4, 2007
Overview of early response assessment in lymphoma with FDG-PETMichael P MacManus, John F Seymour, Rodney J Hicks
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Imaging, radiation oncology and randomised trials: time for a change?Gillian M Duchesne, Shih-Chang Wang, Rodney J Hicks
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 11, 2018
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and PitfallsMichael S Hofman, Rodney J Hicks, Tobias Maurer, et al.
The Lancet. Oncology|August 14, 2018
[<sup>177</sup>Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer - Author's replyMichael S Hofman, John Violet, Rodney J Hicks, et al.
ANZ Journal of Surgery|March 4, 2015
Re: palliative bypass for small bowel carcinoid with mesenteric mass and vascular encasementBenjamin N J Thomson, Michael S Hofman, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake valueThomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 6, 2022
Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasmsAmir Iravani, Ashwin Singh Parihar, Timothy Akhurst, et al.
Current Oncology Reports|April 2, 2008
The role of PET-CT in the management of patients with advanced cancer of the head and neckJune Corry, Danny Rischin, Rodney J Hicks, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodulesJason Callahan, Tomas Kron, Michal E Schneider, et al.
Seminars in Nuclear Medicine|August 16, 2005
Initial staging of lymphoma with positron emission tomography and computed tomographyRodney J Hicks, Michael P Mac Manus, John F Seymour
Pageof 47